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Background: The metabolic syndrome (MetS) and aging are associated with
modifications in blood coagulation factors, vascular inflammation, and increased risk of
thrombosis.
Objectives: Our aim was to determine concomitant changes in thrombin generation
in the blood compartment and at the surface of vascular smooth muscle cells (VSMCs)
and its interplay with adipokines, free fatty acids (FFA), and metalloproteinases (MMPs)
in obese Zucker rats that share features of the human MetS.
Methods: Obese and age-matched lean Zucker rats were compared at 25 and
80 weeks of age. Thrombin generation was assessed by calibrated automated
thrombography (CAT).
Results: Endogenous thrombin potential (ETP) was increased in obese rats independent
of platelets and age. Clot half-lysis time was delayed with obesity and age. Interleukin
(IL)-1β and IL-13 were increased with obesity and age respectively. Addition of
exogenous fibrinogen, leptin, linoleic, or palmitic acid increased thrombin generation
in plasma whereas adiponectin had an opposite effect. ETP was increased at
the surface of VSMCs from obese rats and addition of exogenous palmitic acid
further enhanced ETP values. Gelatinase activity was increased in aorta at both
ages in obese rats and MMP-2 activity was increased in VSMCs from obese rats.
Lagrange et al. Hypercoagulability in Zucker Rats
Conclusions: Our study demonstrated in MetS an early prothrombotic phenotype
of the blood compartment reinforced by procoagulant properties of dedifferentiated
and inflammatory VSMCs. Mechanisms involved (1) increased fibrinogen and impaired
fibrinolysis and (2) increased saturated fatty acids responsible for additive procoagulant
effects. Whether specifically targeting this hypercoagulability using direct thrombin
inhibitors would improve outcome in MetS is worth investigating.
Keywords: vascular aging, blood coagulation test, obesity, fatty acids, thrombin generation
INTRODUCTION
Atherothrombotic events and venous thromboembolism are
associated with the metabolic syndrome (MetS), a cluster of risk
factors for cardiovascular disease including insulin resistance
(IR), abdominal adiposity, dyslipidemia, and hypertension
(Dandona et al., 2005). Likewise, obesity is causally related to
the high prevalence of MetS. Inflammation in MetS results
in endothelial dysfunction and increased arterial stiffness
(Weiss et al., 2013), probably through the action of matrix
metalloproteinases (MMPs; Halcox et al., 2009). Aging is also
associated with intimal thickening, breaks in the internal elastic
lamina and impaired endothelial function leading to increased
arterial stiffness (Wang et al., 1996).
A further cascade of obesity-induced chronic inflammation
leads to increased tissue factor (TF; Samad et al., 2001)
through the NF-κB pathway (Sonnenberg et al., 2004). Von
Willebrand factor (VWF) participates in the prothrombotic state
found in MetS (Lim et al., 2004). Total thrombin generation
and platelet reactivity are increased in type 2 diabetes and
older obese women (Beijers et al., 2010). Furthermore, as far
as fibrinolysis is concerned, chronic inflammation, abdominal
obesity, and IR all increase plasminogen activator inhibitor-1
(PAI-1) production, so reducing plasminogen conversion and
leading to a hypofibrinolytic state (Alessi and Juhan-Vague, 2008;
Suehiro et al., 2012).
Adipokine levels (adiponectin, leptin) as well as free fatty acid
(FFA) metabolism are changed significantly in MetS (Matsuzawa
et al., 2004; Wakil and Abu-Elheiga, 2009). Both are known
also to be directly or indirectly implicated in haemostasis and
increased thrombosis (Konstantinides et al., 2001; Restituto
et al., 2010). Since haemostasis is modified in the MetS
and during aging our hypothesis is that MetS, the related
adipokines, and FFAs have a major impact on haemostasis
changes, increased thrombotic risk and worsen the vascular
phenotype. A major challenge is to elucidate the mechanisms
leading to increased thrombosis during MetS and in the natural
course of aging, and how they are related to the interaction
between blood haemostasis and the vascular wall. Rodent models
that mimic human MetS are major tools for understanding this
pathophysiology (Sloboda et al., 2012).
Obese Zucker rats have a missense point mutation (fa/fa) in
the leptin receptor gene that leads to hyperphagia and marked
obesity (Phillips et al., 1996). These rats display also many other
aspects of the human condition, such as IR, hypertension, and
increased plasma lipid levels. We have shown previously that
obese Zucker rats exhibited an increased age-dependent arterial
stiffening which was greater in obese than lean, as well as
endothelial dysfunction with increased systemic oxidative stress
(Sloboda et al., 2012).
We have developed therefore a strategy combining “adult”
(25-week-old) and “old” (80-week-old) Zucker rats with MetS
characteristics and their lean controls and a vascular smooth
muscle cell (VSMC) approach to investigate the role of FFAs
and vascular inflammation in the prothrombotic properties of
MetS. We first explored thrombin generation and its functional
consequences on the fibrin network and on fibrinolysis in
the blood compartment. To get insights into the underlying
mechanisms we then examined thrombin generation at the
surface of Zucker rat VSMCs and their MMP activity. We
demonstrated that obesity from at least 25 weeks triggers
increased thrombin generation in the blood compartment and at
the surface of VSMCs via increased FFAs and associated vascular
inflammation.
MATERIALS AND METHODS
Animals
Male Zucker rats with the MetS (MSZR, fa/fa; n = 18) and their
age-matched male lean Zucker rat controls (LZR, FA/-; n = 18)
were obtained from the breeding colony (animal facility, Faculty
of Medicine, University of Lorraine, France). The animals were
maintained at a constant temperature of 22–24◦C, with a 12 h
light-dark cycle (light beginning at 8 a.m.) and given free access
to water and standard chow (A04, Scientific Animal Food and
Engineering advance, Augy, France). The metabolic status of
MSZR and LZR has been published previously (Sloboda et al.,
2012).
Eighty weeks of age corresponds to 5 weeks before the mean
maximum life span of rats from our local breeding colony.
This study was carried out in accordance with
recommendations of the Animal Ethics Committee of the
Institut National de la Santé et de la Recherche Médicale and
conformed to the Guide for the Care and Use of Laboratory
Animals, published by the National Institutes of Health. The
protocols were approved by the Animal Ethics Committee of the
Institut National de la Santé et de la Recherche Médicale.
Blood Sampling
Rats were anesthetized with isoflurane and whole blood was
collected via a carotid catheter into syringes containing one-
tenth the volume of 0.106M sodium citrate. Platelet count
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was determined with an automatic cell counter (Micros 60
ABX model, Montpellier, France). Blood was centrifuged at
190 g for 10min at room temperature to obtain platelet-rich
plasma (PRP) and then at 1,750 g for 10min to obtain platelet-
poor plasma. PRP was adjusted to 200 × 109 platelets/l by
addition of autologous platelet-poor plasma and used for platelet
aggregation and thrombin generation. Platelet-free plasma (PFP)
was obtained by centrifugation of platelet-poor plasma at
13,000 g for 30min at 4◦C, and frozen at−80◦C.
Preparation of Arterial Cryo-Sections
Artery cryo-sections were collected in the cross-sectional
orientation and used subsequently for in situ gelatin zymography.
The descending thoracic aorta was embedded in Optimal Cutting
Temperature (OCT) medium and frozen using iso-pentane pre-
cooled in liquid N2 and stored at −80
◦C until cryo-sectioning.
Cryo-sections were cut at a thickness of 5µm and mounted onto
glass slides (Leica, Milton Keynes, UK) and stored at−80◦C until
use.
Cell Culture
The descending thoracic aorta was excised from rats after
isoflurane anesthesia (4.5% in 1.5 l/min dioxygen) and
exsanguination. VSMCs were isolated as described previously
(Ait Aissa et al., 2015). VSMCs were grown in DMEM/F12
supplemented with 10% fetal bovine serum (Lonza, Basel,
Switzerland). For thrombin generation assays, VSMCs at
passages 3–5 were seeded (7,500 cells/well) in 96-well tissue
culture flat-bottom plates (MICROTESTTM96), grown to
subconfluence and washed with HBS before use.
Platelet Aggregation
Blood was centrifuged at 190 g for 4min followed by 70 s at
1,900 g at room temperature to obtain PRP and then platelets
were sedimented by centrifugation at 5,000 g for 4min. Platelets
were re-suspended in Tyrode buffer (5mMHepes, 137mMNaCl,
2.7mM KCl, 12mM NaHCO3, 0.4mM NaH2PO4, 2mM CaCl2,
1mM MgCl2, 5.5mM glucose, pH 7.3). Platelet aggregation was
measured by turbidimetry at 37◦C under stirred conditions.
PRP or washed platelets were adjusted to 200 × 109 platelets/l
and were stimulated by 5µg/ml collagen or 5µM ADP (SD
Innovation, Frouard, France). Aggregation was followed for
10min using a TA-8V aggregometer (SD Innovation).
Thrombin Generation Assay
Calibrated automated thrombinography (CAT) in PRP or PFP
was performed in a microtiter plate fluorometer (Fluoroskan
Ascent, ThermoLabsystems, Helsinki, Finland) using a dedicated
software program (Thrombinoscope BV, Maastricht, The
Netherlands) as reported previously (Regnault et al., 2004).
All reagents were used at half the ordinary volume as follows:
40 µl PRP or PFP, 10 µl of 5 pM recombinant human
tissue factor (TF) (Dade Behring, Marburg, Germany) and
phospholipid vesicles (PV) consisted of phosphatidylcholine-
serine-ethanolamine (PC/PS/PE) 60/20/20 mole% at a final
concentration of 4µM equivalent PS, 10 µl fluorogenic substrate
and calcium. PV were replaced by buffer in PRP and VSMC
experiments. Round-bottom 96-well Greiner blue plates were
used for PFP and PRP, and MICROTESTTM96 plates for VSMC
monolayers. Thrombin generation curves were recorded in
triplicate. Thrombin generation was monitored also following
supplementing PFP with adiponectin or leptin (BioVision, San
Francisco, USA), with fibrinogen (Sigma-Aldrich, St Louis,
USA), or with palmitic acid or linoleic acid (Sigma-Aldrich).
Coagulation and Circulating Parameters
Prothrombin and FVIII were measured in PFP samples diluted
1:40–80 in factor diluent (Instrumentation Laboratory, Le Pré
Saint Gervais, France). For each assay 50 µl of diluted sample
were added to 50 µl of human prothrombin-deficient plasma
(Siemens Healthcare Diagnostics SAS, Saint-Denis, France)
or FVIII deficient plasma (Dade Behring, Deerfield, USA).
After 1min of incubation at 37◦C in a KC10 coagulometer,
coagulation was started by addition of 80 µl of Thromborel R©
S. Calibration curves were generated using the reference plasma
Unicalibrator (Diagnostica Stago, Asnières, France). Fibrinogen
was measured in PFP samples diluted 1:10–20 in Owren–Koller
buffer (Diagnostica Stago, Asnières, France). Unicalibrator was
used to generate calibration curves. After 4min of incubation
at 37◦C in a KC10 coagulometer, coagulation was started by
addition of 100 µl of Fibriquik (Biomérieux-Trinity Biotech,
Bray, Ireland). Antithrombin levels were measured with the
Coamatic R© antithrombin test kit from Chromogenix, and TAT
with the Enzygnost R© TAT micro (Instumentation Laboratory).
TF and TF pathway inhibitor (TFPI) activities were measured in
PFP using the Actichrome R© tissue factor and Actichrome R© TFPI
activity assay respectively (AmericanDiagnostica, Stamford, CT).
PAI-1 levels were measured with the rat PAI-1 total antigen
ELISA kit from Innovative Research, Inc. IL-13 and IL-1β
concentrations were measured with the IL-13 and IL-1 beta
rat ELISA kits from Invitrogen. MMP-9 levels were measured
with the Quantikine rat total MMP-9 immunoassay from R&D
Systems. VCAM-1 was assessed with the rat VCAM-1 ELISA kit
from Elabscience.
In Vitro Fibrinolytic Test
PFP (20 µl) was diluted by addition of 40 µl buffer containing
5 pM recombinant TF, PV at 4µM equivalent PS, 5 nM rabbit
thrombomodulin (TM) (American Diagnostica, Greenwich,
USA) and 4µg/ml recombinant human tissue Plasminogen
Activator (tPA) Actilyse R© (Boehringer Ingelheim, Ingelheim am
Rhein, Germany). Clot formation was initiated by addition of 10
µl of 100mM CaCl2. To monitor clot lysis, absorbance was read
kinetically at 405 nm using a microplate reader. To standardize
the figure, for each sample basal optical density (OD) after lysis
was subtracted from each point of the curve. Half lysis time
was defined as the time required to reach half-maximal variation
in OD.
Microscopy of Fibrin Fiber Ultrastructure
The thrombin generation assay was performed in order to
generate fibrin for fixation using the same TF and PV
concentrations as in the CAT experiments. This was done using
plasma on paper disks and a Rhodamine substrate was used
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(Ninivaggi et al., 2012). Immediately after thrombin generation
was finished (50min for each run), the mineral oil was removed
from the well and a solution of glutaraldehyde (grade I) in
phosphate buffered saline (PBS) (Sorensen’s PBS, pH 7.2) was
applied. This was put at room temperature for 1 h and then kept
at 4◦Covernight. The samples were thenwashed 5 times with PBS
and a secondary fixation was performed in OsO4 (1%) in sodium
cacodylate (200 nM, pH 7.4) for 1 h at RT. The samples were
then dehydrated with increasing concentrations of ethanol each
during 3min (30, 50, 70, 90, 100%) and the last step (100%) was
performed three times. Further dehydration was accomplished
by a hexamethyldisilazane (HMDS)/ethanol solution (1:1) for
3min and HMDS for 10min. The samples were removed from
the wells and left to dry. In order to visualize the samples with a
Phenom G2Pro scanning electron microscopy (SEM) (Phenom-
World, Eindhoven, the Netherlands), they were put on stubs
using carbon tabs and coated with gold.
For each sample, 3–5 pictures were analyzed. Fiber thickness
was measured using ImageJ software (version 1.48v). For each
picture 100 measurements were performed. The density of the
fibers was calculated from the pictures by counting the number
of fibers that crossed a line of 26.8µm (Konings et al., 2011).
Rat Cytokine Antibody Array
The Rat Cytokine Array Panel A (Cat # ARY008) from
R&D system (Minneapolis, MN) was used to probe cytokines
in PFP from MSZR and LZR by following the procedures
recommended by the manufacturer. Bound antibodies were
detected by chemiluminescence using the ImmobilonTM Western
Chemiluminescent HRP Substrate (Millipore, Billerica, MA).
This was performed once with a plasma pool from 5
to 6 animals to reduce inter-animal variability in each
group.
Phospholipid Procoagulant Activity
The chromogenic assay measuring the phospholipid-related
procoagulant activity (PPA) in VSMCs was performed as
described previously for plasma (Wagenvoord et al., 1994;
Membre et al., 2008). VSMCs cultured in 96 well plates were
washed and 50 µl of 50mM Tris, 175mM NaCl, pH 7.9 (TBS)
containing 2 g/l bovine serum albumin (BSA) were added as
well as 50 µl of activated factor X (1.2 nM), activated factor
V (2.4 nM), CaCl2 (15mM) and 50 µl of bovine prothrombin
(6µM) plus Z-Gly-Gly-Arg-AMC substrate (1.25mM) in 20mM
HEPES pH 7.5 containing 60 g/l BSA. The plate was placed
in the Fluoroskan Ascent fluorometer and allowed to warm
up to 37◦C for 5min before kinetic readings were taken
over 10min. Phospholipid concentration was estimated from
the initial rate of thrombin formation by reference to a
standard curve constructed with PV, and expressed as PS
equivalents.
Western Blot
Cell extracts were obtained by lysing VSMCs in complete Lysis-
M buffer (Roche Diagnostics Corporation, Basel, Switzerland).
Detergent-soluble fractions were retained, and protein
concentrations in samples were determined using a Bradford
protein assay (Bio-Rad, Hercule, USA). Lysates containing 30
µg of protein were electrophoresed on polyacrylamide gels
(8% gel), transferred to Hybond-C nitrocellulose membranes
(transblot turbo, Bio-Rad, Hercule, USA) and blotted with
the following antibodies: α-smooth muscle actin (αSMA),
4/1,000 (Sigma-Aldrich), smooth muscle myosin heavy chain
(SM-MHC), 1/1,000 (Abcam; Cambridge, UK); smoothelin,
1/500 (Santa Cruz Biotechnology, USA); integrin αv, 1/1,000
(Santa Cruz Biotechnology, Dallas Texas); integrin β3 1/500
(Merck Millipore, Billerica, USA) and tubulin, 2/1,000 (Sigma-
Aldrich). After rinsing, incubation with a secondary rabbit
antibody 1/1,000 (αv, β3, smoothelin, SM-MHC, Sigma-Aldrich)
and mouse antibody 1/1000 (αSMA, tubulin, Sigma-Aldrich).
Reactions were visualized by the ECL Western Blot Detection
Kit (Bio-Rad, Hercule, USA) after incubation with peroxidase
conjugates 1/2000 (GE Healthcare, Little Chalfont, UK). Tubulin
was used as loading control and the protein expression was
normalized to tubulin.
In Situ Gelatin Zymography
In situ gelatin zymography was performed to determine the
gelatinase activity across the aortic wall using DQ-gelatin
(Life Technologies, Paisley, UK) as described previously (Mook
et al., 2003). Fluorescein isothiocyanate (FITC, 1/110), and 4′,6-
diamidino-2-phenylindole (DAPI, 1/150) filters were used to
visualize the degree of gelatinase activity and the localisation
of nuclear tissue by fluorescence microscopy using a x20
optical objective (Keynece, Osaka, Japan). Analysis of average
fluorescence was performed for three 20µm thick profile lines
across 3 arterial wall regions for each sample.
Zymography Analysis
VSMCs from LZR or MSZR (passage 4–6) were seeded (50,000
cells/well) in 6-well culture plates in DMEM/F-12 supplemented
with 10% fetal bovine serum (life technology Thermo Fisher
Scientific, Waltham, USA). Cells were grown to subconfluence
and after 16 h in serum-free medium, cells were washed with
PBS (Sigma-Aldrich), the medium was changed and cells
were incubated for 4, 8, or 20 h at 37◦C. Conditioned media
were then removed and centrifuged at 500 g for 10min at
room temperature and used for the determination of MMP-2
secretion.
Conditioned media were analyzed for gelatin degradation
by electrophoresis under non-reducing conditions on a 10%
polyacrylamide-SDS gel containing 0.1% gelatin. Gels were
washed for 1 h at room temperature in a 2% triton X-100 solution
and incubated overnight at 37◦C in 50mM Tris–HCl/10mM
CaCl2 (pH 7.6) buffer.
Gels were stained in a 0.1% coomassie Blue (G250)/45%
methanol/10% acetic acid solution and de-stained in a 10% acetic
acid/20% methanol solution. White lysis strips, indicative of
gelatinolytic activity, were revealed and scanned (Fujifilm LAS
4000, Life sciences, Branford, USA). Densitometric analysis was
made using MultiGauge software (Fuji, Tokyo, Japan). Fetal
bovine serum diluted at 1% in serum free medium was used as
a positive control.
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Statistical Analysis
Results are presented as mean± standard error of themean. Data
were analyzed by a one-way or two-way ANOVA, followed by a
Fisher’s test for multiple comparisons to evaluate the influence of
age and strain and their interaction on the different variables. In
the case of SEM measurements, the differences in fiber thickness
were analyzed using the MannWhitney U-test.
RESULTS
Platelet Aggregation, Thrombin
Generation, and Fibrinolysis Were All
Impaired with the MetS and/or Aging
Platelet count in blood was increased in MSZR at both ages
compared to the same aged LZR (Table 1). Platelet aggregation
using washed platelets and collagen as a strong agonist was
not significantly modified as shown by the mean maximum
aggregation (Figure 1A). For platelet aggregation in PRP using
ADP, mean maximum aggregation was increased in 80 week-old
MSZR and LZR compared to 25 week-old controls (Figure 1B).
The F1+2 fragment was analyzed to evaluate the in vivo reactivity
of the coagulation system. The amount of F1+2 fragment was
increased in 25 week-old MSZR compared to the same aged LZR
(Table 1). Thrombin generation measurement was performed as
an integrative in vitro phenotype of coagulation. Adult and very
old MSZR had a significantly increased endogenous thrombin
potential (ETP) compared to same aged LZR. The other thrombin
generation parameters (lag time, peak, and velocity) were not
changed significantly except for the time to peak which was
increased in obese at both ages (Table 1; Figure 1C). The ratio of
thrombin generation in PFP and PRP compared to 25 week-old
LZR was made to evaluate the platelet reactivity impact on
thrombin generation. Interestingly, thrombin generation was
more increased in PRP from MSZR at 25 week of age compared
to 80 week-old rats (Figure 1D). The coagulation parameters,
TF, TFPI, prothrombin and fibrinogen, were all increased in
MSZR compared to LZR at both ages. TFPI was decreased and
fibrinogen was increased with age in MSZR and prothrombin
was increased with age in LZR. FVIII was increased significantly
with age and MetS in 80 week-old MSZR. Antithrombin
measurements showed no modification in MSZR and LZR rats
(Table 1). Fibrin clots were characterized by SEM. Computerised
analysis of the SEM images showed a decrease of fibrin fiber
thickness in MSZR compared to LZR at both ages while fiber
density was only increased in 80 week-old LZR (Figures 1E-G).
Circulating levels of PAI-1 were increased in both 80 week-old
LZR and MSZR (Figure 1H). In a fibrinolysis test (Figure 1I),
half-time lysis was increased in MSZR compared to LZR at
both ages and aging significantly increased half-time lysis in
both groups (Figure 1J). Maximal lysis speed was not modified
(Figure 1K).
Inflammation, Metabolic Factors, and Free
Fatty Acids Modified Thrombin Generation
Fibrinogen concentration was correlated highly to ETP (r =
0.069) and supplementing plasma with exogenous fibrinogen
at concentrations that agreed with the changes between MSZR
and LZR gradually increased ETP (Figures 2A,B). The 1.2-
fold increase in ETP with the 2.5 mg/mL concentration is
consistent with the 1.4 increase in plasma fibrinogen in MSZR.
We have then tested the effects of addition of exogenous
leptin, adiponectin, linoleic acid, and palmitic acid to PFP
at concentrations selected to encompass the range previously
TABLE 1 | Blood coagulation parameters and thrombin generation parameters of LZR and MSZR at 25 and 80 weeks of age.
25 week-old 80 week-old ANOVA
LZR MSZR LZR MSZR Strain Age Interaction
n 9 10 12 9
Platelets (103/mm3) 574 ± 37 789 ± 34* 633 ± 29 834 ± 63* ≤0.0001 0.009 0.013
F1+2 (pmol/l) 4.1 ± 0.5 7.9 ± 1.0* 5.8 ± 1.2 5.5 ± 0.9 0.009 0.7 0.05
TF (pM) 0.3 ± 0.1 12.2 ± 1.7* 2.0 ± 0.4 9.9 ± 1.5* ≤0.0001 0.8 0.09
TFPI activity (U/ml) 4.9 ± 0.2 11.2 ± 0.2* 5.4 ± 0.2 9.9 ± 0.6*# ≤0.0001 0.3 0.01
FVIII (%) 104 28 190 34 124 28 466 52*# ≤0.0001 0.002 0.001
Prothrombin (%) 94 ± 3 223 ± 19* 155 ± 14# 264 ± 16* ≤0.0001 0.002 0.5
AT (%) 129 ± 2 125 ± 2 127 ± 1 123 ± 3 0.04 0.5 0.9
Fibrinogen (g/l) 2.8 ± 0.1 4.0 ± 0.2* 3.1 ± 0.1 4.9 ± 0.2*# ≤0.0001 0.0003 0.2
n 11 11 10 7
Lag time (min) 1.5 ± 0.1 1.7 ± 0.1 1.4 ± 0.1 1.5 ± 0.1 0.09 0.4 0.6
Peak (nM) 99 ± 8 121 ± 9 102 ± 10 117 ± 15 0.07 0.98 0.7
Time to peak (min) 4.4 ± 0.1 5.2 ± 0.3* 4.1 ± 0.1 5.3 ± 0.2* ≤0.0001 0.6 0.3
ETP (nM.min) 395 ± 37 549 ± 52* 362 ± 34 553 ± 76* 0.001 0.8 0.8
Velocity (nM/min) 35 ± 3 37 ± 4 40 ± 4 31 ± 4 0.6 0.98 0.2
Results are mean ± standard error to the mean. *p< 0.05, SMZR vs. LZR at the same age; #p < 0.05, 80 vs. 25 week-old rats in the same strain. F1+2, fragment 1+2; TF, tissue
factor; TFPI, tissue factor pathway inhibitor; AT, antithrombin; ETP, endogenous thrombin potential.
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FIGURE 1 | Platelet aggregation, thrombin generation, and fibrinolysis in LZR and MSZR rats. (A) Mean maximum aggregation in washed platelets in response to
collagen (5µg/ml) and in (B) platelet-rich plasma (PRP) in response to ADP (5µM), with the platelet count adjusted to 200 × 109 platelets/l. (C) Calibrated automated
thrombinography (CAT) in rat plasma. Mean thrombin generation curves in platelet free plasma (PFP) triggered by 5 pM tissue factor in LZR and MSZR at 25 and 80
weeks of age. (D) Endogenous thrombin potential (ETP) in PFP and PRP of 25 and 80 week-old LZR and MSZR, expressed as ratios of values for 25 week-old LZR.
(E) Ultrastructure of fibrin fibers was visualized by scanning electron microscopy. Pictures were made at 10,000 × magnification. (F,G) Fiber thickness and fiber
density of fibrin clot in LZR and MSZR. (H) ELISA results of PAI-1 measured in PFP (n = 17–19). (I) Representative curves of fibrinolytic tests in PFP in LZR and MSZR.
(J,K) Half-lysis time and maximal lysis speed of fibrinolytic tests in LZR and MSZR. Results are mean ± standard error of the mean (n = 7–11). *p < 0.05 vs. LZR at
the same age; #p < 0.05 vs. 25 week-old rats in the same strain.
reported for each molecule in MSZR (Sloboda et al., 2012;
Godin et al., 2013). Addition of leptin or adiponectin elicited
similar concentration-dependent changes in ETP whatever the
group of rat. The two adipokines had opposite effects on
thrombin generation, leptin increased ETP whereas adiponectin
decreased it (Figures 2C,D). The two lower concentrations of
added linoleic acid (0.75 and 1.5 mg/mL) had clear procoagulant
effects whereas the higher concentration (3 mg/mL) was less
effective in increasing thrombin generation (Figures 2E,F).
There was a significant increase in thrombin generation for
all added concentrations of palmitic acid whatever the group
of rat. The results show an additive effect of FFAs on MSZR
plasma.
Plasma Cytokines Were Increased Both
with MetS and Aging
To explore inflammation in our model we performed a plasma
cytokine array of 27 cytokines in order to provide qualitative
data that will subsequently be used to quantify cytokines known
likely to promote prothrombotic phenotypes (Figure 3). Panel
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FIGURE 2 | Effect of fibrinogen, adipokines, and free fatty acids on thrombin generation. (A) Correlation between ETP and plasma fibrinogen concentration of 25 and
80 week-old LZR and MSZR (r = 0.069, p = 0.01). (B) ETP values in 25 week-old LZR platelet free plasma supplemented with 0.5, 1.0, 2.0, or 2.5 g/l fibrinogen.
(C–F) ETP values, expressed as ratios of values in presence of adipokines or free fatty acids to those obtained with no addition for each group, in platelet free plasma
supplemented with 0.05, 0.1, or 1.0 ng/ml leptin (C), with 2, 4, or 8µg/ml adiponectin (D), with 0.75, 1.5, or 3 mg/ml of linoleic acid (E) or with 0.75 1.5, or 3 mg/ml
of palmitic acid (F). Results are mean ± standard error of the mean (n = 11–16). *p < 0.05 vs. no addition.
A presents pictures of the cytokine array membranes. A 50%
variation between two groups was chosen as a threshold to
classify cytokines into four groups. The first group of five
cytokines showed no modifications (Figure 3B), a second group
of eight cytokines were increased with MetS (Figure 3C), a third
group of three cytokines were increased with aging (Figure 3D)
and a last group of 11 cytokines were increased with both MetS
and aging (Figure 3E). The highest variation between 25 week-
old MSZR and LZR was found for IL-1β (>3,000% variation)
and the highest variation between 80 and 25 week-old rats was
observed for IL-13 (>400% variation). ELISAs performed with
individual rat PFP for IL-1β and IL-13 showed an increase of
these cytokine levels in LZR and MSZR with age (Figures 3F,G).
IL-13 was increased also in 80 week-oldMSZR compared to same
aged LZR.
MetS and Aging-Induced Inflammation and
Haemostasis Impairment Were Related to
Alteration of VSMCs
To explore the contribution of VSMCs, thrombin generation
was measured at the surface of cultured VSMCs isolated from
LZR and MSZR. Thrombin generation with PFP from LZR and
MSZR was always increased at the surface of MSZR VSMCs
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FIGURE 3 | Plasma cytokine array in Zucker rats. (A) Cytokine arrays of pooled platelet free plasma from 25 to 80 week-old MSZR and LZR. Relative
chemoluminescence compared to 25 week-old LZR was measured. (B) Unchanged cytokines, (C) cytokines modified with age, (D) with MetS, or (E) both with MetS
and age. ELISAs results for IL-1β (F) and IL-13 (G) measured in PFP (n = 14–18), results are mean ± standard error of the mean, *p <0.05 vs. LZR at the same age;
#p < 0.05 vs. 25 week-old rats in the same strain. VEGF, vascular endothelial growth factor; CINC-1, cytokine-induced neutrophil chemoattractant 1; CINC-3,
cytokine-induced neutrophil chemoattractant 3; GM-CSF, granulocyte macrophage colony stimulating factor; MIP, Macrophage Inflammatory Protein; MIG, C-X-C
motif ligand 9; IP-10, interferon gamma-induced protein 10; CNTF, ciliary neurotrophic factor; INFγ, interferon γ; IL, interleukin.
compared to LZR VSMCs. Remarkably, addition of palmitic
acid in LZR VSMCs increased thrombin generation to the level
of MSZR independently of the PFP used (Figure 4A). MSZR
VSMCs displayed increased procoagulant phospholipids at their
surface compared to LZR VSMCs (Figure 4B). Integrin subunit
αv was increased in MSZR compared to LSZ VSMCs while the β3
subunit was notmodified. VSMC differentiationmarkers α-SMA,
SM-MHC, and smoothelin, interestingly, were all decreased in
MSRZ VSMCs compared to LZR VSMCs (Figures 4C,D). Thus,
in situ gelatin zymography was performed to explore MMP
activity through gelatinase activity (Figure 4E). Figure 4E shows
representative photographs of in situ gelatin zymography in
aorta, gelatinase activity is in green. Mean gelatinase activity
in the aortic wall was increased in 25 and 80 week-old MSZR
compared to age matched LZR aortas (Figure 4F). However,
age did not modulate gelatinase activity. At the cellular level
MSZR VSMCs displayed increased MMP-2 secretion compared
to LZR VSMCs (Figures 4G,H). Circulating levels of MMP-9
were increased in 80 week-old MSZR whereas VCAM-1 was
increased in 25 week-old MSZR compared to same aged LZR and
in 80 week-old LZR (Figures 4I,J).
DISCUSSION
The aim of the present study was to determine concomitant
changes in the haemostasis system and VSMC phenotype and
their interplay with FFAs and MMPs during aging in obese rats
compared to lean rats of the same age. Our results demonstrated
(1) increased thrombin generation in MetS in plasma as early as
25 weeks of age, independently of platelets and at the surface of
VSMCs; (2) reinforcement of this hypercoagulability by reduced
plasma fibrinolysis; (3) no influence of aging on plasma thrombin
generation; (4) an age-related increase in platelet aggregation and
clot half lysis time and, (5) contribution of saturated FFAs to the
increased thrombin generation both in plasma and at the surface
of VSMCs.
Increased thrombotic risk can be attributed to three factors:
abnormalities in the vessel wall, in blood flow, and in haemostasis
including coagulation and fibrinolysis. We found previously that
MSZR presented endothelial dysfunction as shown by increased
circulating VWF. This endothelial dysfunction was exacerbated
during aging as shown by increases in both VWF and soluble
CD146 (Sloboda et al., 2012).
Few studies have used Zucker rats to look at haemostasis
and to our knowledge none have been performed in very old
Zucker rats. Paul et al. found that 12 week-old diabetic Zucker
rats presented unmodified in vitro platelet reactivity (Paul et al.,
2007). Recently Shang et al. have shown increased thrombosis,
increased thrombin generation and decreased fibrinolysis in 7–
10 week-old diabetic Zucker rats (Shang et al., 2014). They found
also decreased platelet reactivity to collagen and ADP in obese
rats in PRP. In PRP, we found increased platelet aggregation
using ADP in 80 week-old MSZR and LZR rats compared to
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FIGURE 4 | Role of smooth muscle cells in thrombin generation. (A) ETP values measured at the surface of vascular smooth muscle cells (VSMCs) from LZR and
MSZR, with LZR or MSZR platelet free plasma (PFP), and with or without 1.5 g/l exogenous added palmitic acid (PAL). Results are mean ± standard error of the
mean, n = 3 with 6 wells per condition per experiment. *p < 0.05 vs. LZR VSMC, #p < 0.05 vs. LRZ PFP and LRZ VMSC. (B) VSMC associated procoagulant
activity reported as phosphatidylserine (PS) equivalent in LRZ and MSZR. Results are mean ± standard error of the mean (n = 25). *p < 0.05 vs. LZR. (C) Typical
Western blot and (D) quantification analysis of VSMC differentiation markers (αSMA, SM-MHC, and smoothelin) and integrin subunits (αv and β3) in cultured VSMCs.
(Continued)
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FIGURE 4 | Continued
Results, expressed as fold change vs. VSMCs from LZR, are mean ± standard error of the mean (n = 6). *p < 0.05, MSZR vs. LZR. (E) Representative images of
gelatinolytic metalloproteinase activity in the aorta was measured using in situ gelatin zymography for each group of Zucker rats. Fluorescence as marker for
intra-plaque gelatinolytic activity was quantified. Nuclei were visualized by DAPI staining. (F) Average wall fluorescence of the gelatinolytic metalloproteinase activity in
the aorta. (G) Representative images of zymography gels of LZR and MSZR VSCMCs supernatant at 4, 8, and 20 h. (H) Relative MMP-2 activity in LZR and MSZR
VSMC supernatant at 4, 8, and 20 h. Results are mean ± standard error of the mean (n = 5). *p < 0.05, MSZR vs. LZR. ELISAs results of MMP-9 (I) and VCAM-1 (J)
measured in PFP (n = 17–22). *p < 0.05 vs. LZR at the same age; #p < 0.05 vs. 25 week-old rats in the same strain.
25 week-old controls, but not between rats of the same age. In
addition, we were not able to aggregate platelets using collagen.
Washed platelets were able to aggregate when triggered with
collagen but we did not find any significant changes with obesity
or with age. These changes might be related to the metabolic
differences existing between rats since they used diabetic Zucker
rats while we used obese Zucker rats that only develop diabetes
very late with age. Moreover, platelet count was not modified
in the diabetic Zucker rats of the Shang et al. study while we
found a 25% increased count in MSZR compared to LZR at both
ages. Interestingly, platelet-related thrombin generation showed
a very important increase in 25 week-old MSZR compared
to thrombin generation made with PFP. Altogether, increased
platelet aggregation to ADP with age concomitant to increased
platelet count in obese Zucker rats is in favor of a prothrombotic
state.
To better assess the prothrombotic state in obese and aged rats
we investigated in vivo thrombin generation by measuring F1+2
fragments, which were increased in MSZR indicating increased
in vivo formation of thrombin with MetS. As expected, MetS also
increased the in vitro thrombin generation capacity of plasma,
but this ability was not modified with age. This change in the in
vitro reactivity of the coagulation system points out the role of
several components including metabolic factors and the vascular
wall. Regarding individual clotting factors it was clear that TF
increased in MSZR as well as its inhibitor (TFPI). Increased
prothrombin concentration leads to higher thrombin generation
and can contribute to the increased ETP in MSZR. Other
procoagulant factors such as FVII, FVIII, and VWF are known
to be increased with MetS and aging. Metabolic factors such as
leptin and adiponectin can participate in haemostasis. Leptin has
been suggested previously to represent a link between obesity and
atherothrombosis (Petrini et al., 2016). It has been reported that
leptin enhanced platelet aggregation while adiponectin reduced
it (Konstantinides et al., 2001; Restituto et al., 2010). Adiponectin
has been involved also in the endothelium anticoagulation
function (Lee et al., 2011) since it increased endothelial TFPI
synthesis (Chen et al., 2008). We found in all Zucker rats a
strong positive correlation between plasma TPFI and adiponectin
concentrations dosed previously (data not shown; Sloboda et al.,
2012). Moreover, in our study, we found for the first time that
leptin increased ETP and that adiponectin decreased it. Despite
it being a modest effect, it argues for a major involvement of
adipokines in the regulation of thrombin generation.
Fibrinogen concentration was correlated also to ETP and
we confirmed that increased plasma fibrinogen increased ETP
(Kumar et al., 1994). Thrombin linked to fibrin can possibly
be protected from inhibition by antithrombin, in the same way
as it is protected from inhibition when bound to TM (Bourin,
1987). This may participate in explaining the increased time to
peak observed in MSZR and increased ETP with no significantly
increased peak.
We found that fibrinogen concentration was increased in
MSZR and during aging. In favor of the relevance of this result
it has been shown that synthesis of fibrinogen is upregulated
by inflammatory cytokines such as IL-6 (Morozumi et al.,
2009). The consequence of an increased thrombin generation
was an increased fibrin network formation in MSZR as shown
by thinner fibrin fibers (Wolberg, 2007). The increase in PAI-
1 with aging in LZR as well as in MSZR is relevant to
human physiology since it is known that during aging PAI-
1 is associated with an increased thrombotic risk. In addition,
the fibrinogen concentration increased during aging but the
mechanisms underlying this association with thrombotic risk are
unclear (Cesari et al., 2010). Human fibrinolysis is also impaired
in the MetS with a decrease in clot lysis ability linked to increased
PAI-1 (Pandolfi et al., 2001). Organization of the fibrin network is
likely due to the increased thrombin generation found in MSZR
(Wolberg, 2007). Moreover, clots with thinner fibrin fibers are
more resistant to lysis than clots with thick fibers (Gabriel et al.,
1992). This is supported by the increased half-time lysis found in
MSZR and very old Zucker rats. Other factors must be implicated
since fiber thickness was unchanged with age in both groups
whereas fibrinolysis time increased only during aging indicating
the formation of a denser clot. In line with this, adiponectin may
act as an anticoagulant molecule. Indeed, full length adiponectin
reduces platelet aggregation, inhibits TF and enhances TFPI
expression at the surface of endothelial cells (Chen et al., 2008;
Restituto et al., 2010). Both adiponectin and IL-13 increase the
expression of MMPs which can degrade fibrinogen (Hotary et al.,
2002; Wanninger et al., 2011; Firszt et al., 2014). Consistent
with this, we found an increase in IL-13 plasmatic concentration
with aging and also with the MetS in 80 week-old MSZR which
presents the same variations as plasma levels of MMP-9 and
FVIII. Whether adiponectin interplays directly with fibrinogen
remains an open question. The increase in FVIII with MetS and
associated inflammatory stimuli was anticipated in Zucker rats as
it is in humans (Begbie et al., 2000; Kotronen et al., 2011).
Inflammation during aging and in the MetS triggers vascular
remodeling. Fibrinogen (Lominadze et al., 2010) as well as fibrin
and fibrin degradation products have proinflammatory functions
that can modify VSMC phenotype (Lu et al., 2011). Cytokines in
the plasma, as shown in the array presented here, are increased
by the MetS, aging, or both. Our data indicated that the more
relevant proinflammatory cytokines such as IL-1α, IL-1β, IL-2,
IL-3, and IL-6 were increased early with the MetS while few
Frontiers in Physiology | www.frontiersin.org 10 November 2017 | Volume 8 | Article 949
Lagrange et al. Hypercoagulability in Zucker Rats
anti-inflammatory cytokines were increased with MetS and aging
(IL-10, IL-1ra, IL-17). Our cytokine array made with a pool of
plasma for each group was checked using ELISA measurements
with individual samples for the two main cytokines involved in
the regulation of haemostasis (IL-13 and IL-1β). IL-13 changes
were confirmed while IL-1β increased only with aging but not
with the MetS at 25 weeks of age. This points to a determinant
role of age in complex vascular pathologies including several
comorbidities. IL-1β has a pleiotropic effect in the development
of atherothrombosis through its action on leukocyte adhesion to
the vascular wall and induction of procoagulant activity (Libby
et al., 1986; Dinarello, 2011). Recently, inhibition of IL-1β and
subsequent reduction of inflammation (without modification of
lipid levels) in patients with previous episodes of myocardial
infarction was found to reduce recurrent cardiovascular events
(Ridker et al., 2017). These findings are in line with the increase
of circulating IL-1β and increased activity of haemostasis with
age we observed in MSZR. Therefore, exploration of haemostasis
function in MSZR with inhibition of IL-1β could be of interest.
Other factors related to MetS that can potentiate the
modifications we observed in MSZR haemostasis are FFAs.
Saturated FFAs such as palmitic acid are known to be
associated with ischemic heart disease and increase postprandial
concentrations of fibrinogen (Simon et al., 1995; Pacheco et al.,
2006). One other mechanism proposed recently to explain the
thrombogenic effect of palmitic acid was its ability to induce
extracellular release of histones (Shrestha et al., 2013). Histones
are known to promote thrombin generation through platelet
activation (Semeraro et al., 2011). Additionally, palmitic acid
was measured recently in diabetic Zucker rats pointing out a
2.75 times increased concentration in obese rats (0.68 g/l in LZR
vs. 1.87 g/l in MSZR) (Godin et al., 2013). A similar increase
was observed for a polyunsaturated FFA, linoleic acid. We
supplemented 25 week-old LZR PFPwith linoleic or palmitic acid
to reach MSZR plasma concentrations. We showed for the first
time a direct effect of FFAs on thrombin generation confirming
the prothrombotic effect of palmitic acid.
All these FFAs, pro-inflammatory cytokines and coagulation
factors can have deleterious effects on the vascular wall. We
have shown previously the presence of endothelial dysfunction
in MSZR (Sloboda et al., 2012). In the present study we studied
VSMCs in more detail. Interestingly, thrombin generation
measured at the surface of VSMCs from MSZR was increased
compared to LZR VSMCs. This increase can be related to the
increased procoagulant phospholipids at the surface of MSZR
VSMCs. We showed recently that thrombin generation at the
surface of VSMC from spontaneously hypertensive rats (SHR)
leads to increased ETP and VSMCs were responsible for a
prothrombotic phenotype in SHR rats. In the same way as for
SHR rats, increased VSMC-supported thrombin generation can
be a mechanism implicated in the prothrombotic phenotype
we have observed in Zucker rats. In these cellular experiments
addition of palmitic acid exacerbated also thrombin generation
over MSZR VSMCs.
MMPs are related to FFAs, obesity-related diseases such as
type 2 diabetes and overall, inflammation. In our model, mean
gelatinase activity, focusing on MMP-2 and-9 activities, was
increased in MSZR. These molecules are responsible for the
degradation of type IV collagen, elastin, fibronectin, and laminin,
among other proteins. It is known that FFAs and insulin lead
to hyperactivity of MMP-2 and-9 (Boden et al., 2008). The
close relation between MMPs and insulin was demonstrated
also in Zucker rats (Zhou et al., 2005). IL-13 was increased
in old rats and is known to be an activator of MMPs (Firszt
et al., 2014). This increase in aortic MMP activity in the intima
with aging has been described in rats and was 2-fold higher
in old vs. young non-human primates (Li et al., 1999; Wang
et al., 2007). In addition, MMP activity may participate also
in age-related vascular remodeling in the aortic media since
MMPs accumulate around elastic fibers in the aortic media
(Li et al., 1999), which become fragmented with age-associated
increases in arterial stiffness which thus increases cardiovascular
risk. Interestingly, MMP production can be stimulated through
integrin αvβ3 (Bendeck et al., 2000). Concerning this pathway, we
found an increase of the αv subunit in MSZR VSMCs and MMP-
2 secretion was increased in MSZR compared to LZR. Moreover,
we have shown previously that this integrin is responsible for
thrombin generation supported by VSMCs and it argues for its
role in vascular remodeling (Mao et al., 2012). Very interestingly
all VSMC differentiation markers we tested were downregulated
inMSZR and even absent concerning SM-MHC. This illustrates a
phenotype switch from contractile to secreting VSMCs occurring
in vascular diseases such as atherosclerosis (Lacolley et al.,
2012).
In conclusion, our study demonstrates in MetS a
prothrombotic phenotype of the blood compartment reinforced
by procoagulant properties of the vascular wall. Regarding the
mechanisms, fibrinogen contributes to this hypercoagulable
phenotype in plasma at an early stage of MetS. Leptin and
adiponectin exert moderate opposite effects on thrombin
generation precluding a major contribution of adipokines. An
increase in proinflammatory cytokines likely increased MMP
activity inducing a VSMC dedifferentiated phenotype exhibiting
procoagulant properties. An increase in FFAs contributes to the
increased thrombin generation both in plasma and at the surface
of VSMCs. Plasma from MSZR and palmitic acid elicit additive
procoagulant effects. The potential benefit of direct thrombin
inhibitors should be investigated both on haemostatic balance in
blood compartments and on the cellular phenotypic modulation
within the vessel wall, and MMP production in MetS and its
complications with aging.
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